July 21st 2023
Closing out their discussion on uncommon EGFR mutations in non–small cell lung cancer, Benjamin Levy, MD, and Estelamari Rodriguez, MD, MPH, consider how the treatment paradigm will continue to evolve.
March 18th 2021
Benjamin P. Levy, MD, discusses the importance of testing for KRAS mutations in lung cancer.